Viewing 3 reply threads
  • Author
    • #21197
      DeAnn R

      I’m sure you’ve heard by now that one of the trials for AVXS-101 is on hold.  You can read more about it here. From my interpretation there are negative side effects from the IT delivery method of the drug commonly known as Zolgensma in animal studies. IT is the delivery method they’re looking at for those of us older than 2 years old. On one hand it’s frustrating. It seems so close but now it’s slipping through our fingers. On the other hand I’m glad they’re taking the time to get it right. Besides that, there are other drugs in the pipeline. Zolgensma however is the only one that I’m aware of that targets the root cause of SMA. I know I’ll be keeping a close eye on further developments. What do you think about the news? Would it make you hesitant to participate in future human trials?

    • #21226
      Robert Stump

      It makes me sad to learn that Zolgensma may not ultimately be viable for us adults, and yes it definitely slows me down when considering partaking in any future trials for this drug.

    • #21231
      Halsey Blocher

      This is a bummer. I’m already consider Risdiplam as better option for me, but it’s still disappointing. However, I have to agree that it is best that they are finding these problems now before it’s used on people.

    • #21236
      Alyssa Silva

      That is definitely disappointing to some degree, especially since this drug holds such promise in essentially correcting SMA. However, I’m not sure it would deter me from taking it down the road just because, as Halsey said, they’re finding all the problems now as to prevent them from happening in adults.

Viewing 3 reply threads
  • You must be logged in to reply to this topic.

©2022 KLEO Template a premium and multipurpose theme from Seventh Queen


We're not around right now. But you can send us an email and we'll get back to you, asap.


Log in with your credentials


Forgot your details?

Create Account